Atlas Trials

Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia

Clinical trial NCT04380376 · UNKNOWN

Trial details

NCT number
NCT04380376
Sponsor
Federal State Budgetary Institution, Pulmonology Scientific Research Institute
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19Viral Pneumonia
Start date
2020-04-30
Primary completion
2020-10-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.